These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8303684

  • 1. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR, Sobel BE.
    Thromb Res; 1993 Dec 01; 72(5):413-21. PubMed ID: 8303684
    [Abstract] [Full Text] [Related]

  • 2. The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.
    Serizawa K, Urano T, Kozima Y, Takada Y, Takada A.
    Thromb Res; 1993 Aug 15; 71(4):289-300. PubMed ID: 8236158
    [Abstract] [Full Text] [Related]

  • 3. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
    Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D.
    Blood; 1994 Jan 15; 83(2):351-6. PubMed ID: 8286735
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).
    Huebner BR, Moore EE, Moore HB, Stettler GR, Nunns GR, Lawson P, Sauaia A, Kelher M, Banerjee A, Silliman CC.
    Shock; 2018 Dec 15; 50(6):671-676. PubMed ID: 29280928
    [Abstract] [Full Text] [Related]

  • 6. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb 02; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 8. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV, Jerome WG, Hantgan RR.
    Blood; 1994 Feb 15; 83(4):982-93. PubMed ID: 8111066
    [Abstract] [Full Text] [Related]

  • 9. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
    Pósán E, Ujj G, Kiss A, Telek B, Rák K, Udvardy M.
    Thromb Res; 1998 Apr 15; 90(2):51-6. PubMed ID: 9684757
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
    Stringer HA, van Swieten P, Heijnen HF, Sixma JJ, Pannekoek H.
    Arterioscler Thromb; 1994 Sep 15; 14(9):1452-8. PubMed ID: 8068607
    [Abstract] [Full Text] [Related]

  • 11. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV, Handt S, Jerome WG, Kirkpatrick J, Lewis JC, Hantgan RR.
    Blood; 1993 Mar 01; 81(5):1290-9. PubMed ID: 8443390
    [Abstract] [Full Text] [Related]

  • 12. Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.
    Shohet RV, Spitzer S, Madison EL, Bassel-Duby R, Gething MJ, Sambrook JF.
    Thromb Haemost; 1994 Jan 01; 71(1):124-8. PubMed ID: 8165630
    [Abstract] [Full Text] [Related]

  • 13. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 01; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V, Pannell R.
    Thromb Res; 1986 Oct 15; 44(2):217-28. PubMed ID: 3097872
    [Abstract] [Full Text] [Related]

  • 15. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.
    Reilly CF, Fujita T, Mayer EJ, Siegfried ME.
    Arterioscler Thromb; 1991 Oct 15; 11(5):1276-86. PubMed ID: 1911713
    [Abstract] [Full Text] [Related]

  • 16. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP, Gurewich V, Johnstone M, Pannell R.
    Thromb Haemost; 1994 Mar 15; 71(3):347-52. PubMed ID: 8029800
    [Abstract] [Full Text] [Related]

  • 17. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec 15; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 18. Platelets retain high levels of active plasminogen activator inhibitor 1.
    Brogren H, Wallmark K, Deinum J, Karlsson L, Jern S.
    PLoS One; 2011 Dec 15; 6(11):e26762. PubMed ID: 22069469
    [Abstract] [Full Text] [Related]

  • 19. The role of the finger domain of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in initiation and progression of thrombolysis.
    Stringer HA, van Swieten P, Horrevoets AJ, Smilde A, Pannekoek H.
    Thromb Haemost; 1994 Dec 15; 72(6):900-5. PubMed ID: 7740461
    [Abstract] [Full Text] [Related]

  • 20. The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.
    Carrieri C, Galasso R, Semeraro F, Ammollo CT, Semeraro N, Colucci M.
    J Thromb Haemost; 2011 Jan 15; 9(1):154-62. PubMed ID: 20961395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.